BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28429331)

  • 1. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
    Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
    Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
    Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 5. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
    Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
    Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
    Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
    Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24
    Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
    Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the proportion of CD24
    Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
    Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients.
    Song H; Xi J; Li GG; Xu S; Wang C; Cheng T; Li H; Zhang Y; Liu X; Bai J
    Intern Emerg Med; 2016 Apr; 11(3):415-23. PubMed ID: 26758063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating CD19
    Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
    Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective CD19+CD24
    Cencioni MT; Ali R; Nicholas R; Muraro PA
    Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and Immunophenotypic Characterization of Human CD19
    Bradford HF; Mauri C
    Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
    Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
    Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD19
    Gu Y; Li K; Sun J; Zhang J
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
    Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
    Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.